- Home
- G vs ICLR Comparison
G vs ICLR Comparison
Compare G & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | G | ICLR |
|---|---|---|
| Founded | 1997 | 1990 |
| Country | Bermuda | Ireland |
| Employees | 140000 | N/A |
| Industry | Professional Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.1B |
| IPO Year | 2007 | 2001 |
Fundamental Metrics
Financial Performance| Metric | G | ICLR |
|---|---|---|
| Price | $40.03 | $109.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | $49.50 | ★ $194.38 |
| AVG Volume (30 Days) | 3.0M | ★ 3.6M |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.89% | N/A |
| EPS Growth | ★ 9.82 | N/A |
| EPS | ★ 3.13 | N/A |
| Revenue | ★ $2,279,438,000.00 | N/A |
| Revenue This Year | $9.23 | N/A |
| Revenue Next Year | $7.26 | N/A |
| P/E Ratio | ★ $12.62 | $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $34.79 | $66.57 |
| 52 Week High | $52.83 | $211.00 |
Technical Indicators
Market Signals| Indicator | G | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 48.03 | 37.08 |
| Support Level | $38.23 | $66.57 |
| Resistance Level | $40.44 | $189.62 |
| Average True Range (ATR) | 1.37 | 8.46 |
| MACD | 0.43 | 1.54 |
| Stochastic Oscillator | 93.07 | 48.37 |
Price Performance
Historical ComparisonAbout G Genpact Limited
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.